Cognitive performance before and after the onset of subjective cognitive decline in old age  by Koppara, Alexander et al.
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 194-205Cognitive performance before and after the onset of subjective
cognitive decline in old ageAlexander Kopparaa,b,*, Michael Wagnera,b, Carolin Langec, Annette Ernstc,
Birgitt Wiesed, Hans-Helmut K€onige, Christian Brettschneidere, Steffi Riedel-Hellerf,
Melanie Luppaf, Siegfried Weyererg, Jochen Werleg, Horst Bickelh, Edelgard M€oschh,
Michael Pentzeki, Angela Fuchsi, Steffen Wolfsgrubera,b, Andre Beauducelj,
Martin Schererc, Wolfgang Maiera,b, Frank Jessenk,b
aDepartment of Psychiatry and Psychotherapy, Rheinische-Friedrich-Wilhelms University, Bonn, Germany
bGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
cDepartment of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
dInstiute of General Practice, WG Medical Statistics and IT-Infrastructure, Hannover Medical School, Hannover, Germany
eDepartment of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany
fDepartment of Psychiatry, University of Leipzig, Leipzig, Germany
gDepartment of Psychiatry and Psychotherapy, Psychiatric Epidemiology and Demographic Change, Central Institute of Mental Health, Medical Faculty
Mannheim, Heidelberg University, Mannheim, Germany
hDepartment of Psychiatry, Technical University, Munich, Germany
iDepartment of General Practice, University Medical Center D€usseldorf, D€usseldorf, Germany
jInstitute of Psychology, Methods, Assessment, & Evaluation, Rheinische-Friedrich-Wilhelms University, Bonn, Germany
kDepartment of Psychiatry, University of Cologne, Medical Faculty, Cologne, GermanyAbstract Background: Our objectives were (1) to test the association between the report of subjectiveConflict of interes
ests.
Funding: This stu
mentia (KND) and th
mentia (KNDD), and
Education and Re
01GI0422, 01GI042
http://dx.doi.org/10.10
2352-8729/ 2015 T
licenses/by-nc-nd/4.0/cognitive decline (SCD) and prospective objective cognitive performance in high age individuals
and (2) to study the course of longitudinal cognitive performance before and after the first report
of SCD.
Methods: Cognitively normal elderly participants of the German Study on Ageing, Cognition,
and Dementia study (N 5 2330) with SCD (subjective decline in memory with and without asso-
ciated concerns) and without SCD at baseline were assessed over 8 years with regard to imme-
diate and delayed verbal recall, verbal fluency, working memory, and global cognition. Baseline
performance and cognitive trajectories were compared between groups. In addition, cognitive tra-
jectories before and after the initial report of SCD (incident SCD) were modelled in those
without SCD at baseline.
Results: Baseline performance in the SCD group was lower and declined more steeply in immediate
and delayed verbal recall than in the control group (no SCD at baseline). This effect was more pro-
nounced in the SCD group with concerns. Incident SCD was preceded by decline in immediate and
delayed memory and word fluency.t disclosure: The authors report no competing inter-
dy is part of the German Research Network on De-
e German Research Network on Degenerative De-
was funded by the German Federal Ministry of
search (grants KND: 01GI0102, 01GI0420,
3, 01GI0429, 01GI0431, 01GI0433, 01GI0434;
grants KNDD: 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714,
01GI0715, 01GI0716).
*Corresponding author. Tel.: 149-228-287-16946; Fax: 149-228-287-
16097.
E-mail address: alexander.koppara@ukb.uni-bonn.de
16/j.dadm.2015.02.005
he Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
).
A. Koppara et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 194-205 195Conclusions: SCD predicts future memory decline. Incident SCD is related to previous cognitive
decline. The latter finding supports the concept of SCD indicating first subtle decline in cognitive per-
formance that characterizes preclinical Alzheimer’s disease.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Subjective cognitive decline; Preclinical Alzheimer’s disease; Early detection1. Introduction
Evidence from clinical and epidemiological studies sug-
gests that subjective cognitive decline (SCD) may represent
the initial symptomatic manifestation of Alzheimer’s disease
(AD) before mild cognitive impairment (MCI) [1]. A num-
ber of studies found that subjective cognitive decline
(SCD) in the cognitively normal elderly is associated with
an increased risk of dementia [2–4] particularly in cases
where individuals report concern about memory decline
[5]. Hypothetically, SCD may represent the self-experience
of subtle cognitive decline, before impairment on cognitive
tests occurs [1].
Cross-sectional studies in epidemiological samples, how-
ever, often did not find an association between SCD
and objective memory performance [6–8]. In large cohorts,
weak associations between SCD and memory performance
in unimpaired elderly individuals have been observed [9–
12]. One potential explanation for the small magnitude of
the cross-sectional association of SCDwith cognitive perfor-
mance is that SCD relates to individual cognitive trajectories
(decline) rather than to cross-sectional abilities.
Only a few studies have addressed the association of
SCD with trajectories of cognitive decline. Those with
follow-up periods of less than 5 years did not find such as-
sociations [13,14]. However, Jorm et al. [15] assessed 331
elderly nondemented individuals over 70 years of age three
times over 7.6 years and showed that memory complaints
were associated with past memory performance and future
memory decline. In that study, anxiety and depression
were the strongest predictors of memory complaints. In a
population cohort aged 62 to 85 years, (N 5 1168), Dik
[16] found that baseline memory complaints were associ-
ated with a decline in delayed memory, information pro-
cessing speed, and overall cognition on the Mini-Mental
State Examination (MMSE) over 6 years. Hohman et al.
[17] repeatedly assessed 98 cognitively normal subjects
(mean age 5 75 years) with various cognitive instruments
including the Cognitive Failures Questionnaire (CFQ) dur-
ing an average of 11.5 years. Higher CFQ values, aggre-
gated over several follow-ups, were associated with the
speed of decline in immediate and delayed verbal memory.
This relationship was not present in figural memory or exec-
utive function.
These studies with extended follow-up suggest that in
elderly subjects SCD may be associated with accelerated
memory decline. It is not known, however, how specific
concerns (worries) associated with SCD affect the risk ofcognitive decline as opposed to SCD without concerns.
Also it is not known to what extent the decline in individual
cognitive domains occurs before the first report of SCD.
In this study, we examine the relationship of subjective
decline in memory, as one particular type of SCD, in associ-
ation with and without concerns with future and preceding
performance in different cognitive domains. We assessed a
large cohort of unimpaired elderly subjects over 8 years
and conducted growth curve modeling (GCM) of cognitive
performance data.
2. Methods
2.1. Sample
The German Study on Ageing, Cognition, and Dementia
(AgeCoDe) in primary care patients is an ongoing multi-
center prospective study in elderly individuals with a focus
on the identification of risk factors and predictors of cogni-
tive decline and dementia. Details about the sampling
method and selection process are described in previous pub-
lications [5]. A total of 3327 subjects free of dementia at
baseline were recruited from general practitioner (GP) regis-
tries and assessed with structured clinical interviews and
cognitive tests. Main inclusion criteria were ages greater
than 75 years, native German language, absence of severe
hearing or vision impairments, and residing at home rather
than in an institution. The approval of this study was pro-
vided by the local ethics committees of the Universities of
Bonn, Hamburg, D€usseldorf, Heidelberg/Mannheim, Leip-
zig, and Munich. All subjects gave written informed consent
before the participation in this study.
2.2. Assessment
Subjects were interviewed in their home environment by
trained psychologists or physicians at baseline and at all
follow-up examinations, which were 18 months apart.
Subjective memory capacity was assessed with the ques-
tion: “Do you feel like your memory is becoming worse?”
The possible answers were “no,” “yes, but this does not
worry me,” or “yes, this worries me.” The same question
was asked at each of five follow-up visits, which occurred
at 18 months intervals.
A 10-item word list learning task and a semantic verbal
fluency task from the Consortium to Establish a Registry
of Alzheimer’s Disease (CERAD) neuropsychological bat-
tery [18], was applied at baseline and at all follow-ups.
The CERAD 10-item word list consists of three immediate
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recalled words across three presentations of the list. Delayed
recall refers to the free recall of the 10-item word list after a
delay of approximately 10 minutes filled with other tasks.
The CERAD verbal fluency test consists of a 1-minute
task for naming animals. The number of correct names
given, without duplicates, is used as the score.
In addition, we administered the Structured Interview for
the diagnosis of dementia of the Alzheimer type, multi-
infarct dementia and dementia of other etiology according
to the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition and International Classification of Dis-
eases, Tenth Revision (ICD-10) (SIDAM) [19]. The
cognitive assessment of the SIDAM (SISCO) contains the
Mini-Mental State Examination (MMSE) [20] and addi-
tional items for the assessment of four different areas of
cognition: orientation, memory, intellectual abilities, and
higher cognitive functions (subscales verbal working mem-
ory, constructional abilities, aphasia, and apraxia). For this
study, a verbal working memory composite score was
used, which consists of seven items, including subtraction
calculations (e.g. 9-3 5 ?), backward spelling of a word,
and backward digit span. The MMSE served as a measure
of global cognition in the present analyses.
Depressive symptoms were assessed with the 15-item
version of the Geriatric Depression Scale (GDS) [21]. Level
of education was categorized as low, middle, or high using
the Comparative Analysis of SocialMobility in Industrial Na-
tions educational classification instrument [22]. apolipopro-
tein (APOE) ε4 genotyping was performed in all subjects.
At follow-up, dementia was diagnosed according to
DSM-IV criteria, applying the diagnostic algorithm of the
SIDAM that makes use of the SISCO score as a cognitive
measure and impairment in activities of daily living scale
(SIDAM ADL scale). The diagnosis of AD-type dementia
was made according to the National Institute of Neurolog-
ical and Communicative Disorders and Stroke-Alzheimer’s
Disease and Related Disorders Association criteria. All di-
agnoses were made in consensus by the interviewer, experi-
enced geriatric psychiatrists, or geriatricians.
For those subjects, who could not be interviewed in person
at follow-up the Global Deterioration Scale [23] and the sub-
scales “Changes in Performance of Everyday Activities” and
“Changes in Habits” of the Blessed Dementia Scale [24] were
completed by the interviewer with an informant (spouse, rela-
tive, caregiver) and/or with the GP. Based on this information
the diagnosis of dementia was established.2.3. Group definitions
Only cognitively normal subjects (n5 2330), performing
within 1 standard deviation (SD) of the normative SISCO
domain scores, derived in an independent study [25], at base-
line were included in the present analyses.
Subjects with a negative response to the SCD question
(see section 2.2) served as controls (CO, n 5 993), andwere compared with subjects reporting a memory decline,
either without associated concerns (worries) (SCD-C,
n 5 965), or with associated concerns (SCD1C, n 5 372).2.4. Follow-up assessment rates
Five follow-up waves with 18months intervals after base-
line are the basis for the present analyses. The number of per-
sonal interviews was 2049 (87.9%) at follow-up 1, 1825
(78.3%) at follow-up 2, 1505 (64.6%) at follow-up 3, 1259
(54%) at follow-up 4, and 1037 (44.5%) at follow-up 5.
The main reasons for not obtaining a personal interview
were (1) refusal of a personal visit because of several rea-
sons, including, but not limited to bad medical conditions
(follow-up 1: 58.7%, follow-up 2: 47.4%, follow-up
3: 47.2%, follow-up 4: 24.2%, follow-up 5: 15.4%) and
(2) death (follow-up 1: 32%, follow-up 2: 48%, follow-up
3: 41.5%, follow-up 4:36.7%, follow-up 5: 36.5%).
Informant-based information on those participants without
personal interview was obtained on 273 participants at
follow-up 1, on 222 at follow-up 2, on 316 at follow-up
3, on 197 at follow-up 4, and on 180 at follow-up 5. The
combined follow-up rates (personal interview, informant-
based information only) were 99.7% at follow-up 1, 87.9%
at follow-up 2, 78.2% at follow-up 3, 62.5% at follow-up
4, and 52.2% at follow-up 5. Note that individuals were
not followed-up anymore in the case of incident dementia
or informant-based information only at one follow-up.2.5. Statistical analyses and modeling
In the first set of analyses, we modeled cross-sectional and
longitudinal group differences (according to SCD status at
baseline) in each cognitive domain (verbal immediate and de-
layed recall, verbal fluency, working memory, global cogni-
tion) of those subjects with personal interview including all
follow-ups. In addition, we conducted analyses with reduced
number of follow-ups to investigate theminimal time span af-
ter which differential decline became significant.
GCMwere estimated withMplus 7 [26]. A quadratic term
was included where it improved the models over fitting only
a linear trend [27]. Participant attrition and missing data
were addressed with the full information maximum likeli-
hood method [28]. Time was treated with fixed time scores
as intervals between measurements were approximately of
equal distance. The Akaike Information Criterion, Bayesian
information criterion (BIC), sample size adjusted BIC, root
mean square error of approximation (RMSEA) [29], chi
square fit index, and comparative fit index (CFI) [30] were
used as indices of model fit. A CFI value greater than 0.95
and an RMSEA value of 0.04 or less indicate a very good
model fit [31,32]. The maximum likelihood with robust
standard errors method was used for model estimation,
allowing for robust estimation even if the assumption of
normal distribution was challenged. We report maximum
likelihood parameter estimates and significance values.
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dle and Grimm [33], we used an unconditional model to es-
timate the dependent variables without covariates (Model 1).
If the amount of variance unexplained by Model 1 remained
significant, age, gender, years of education, GDS score
(dichotomized at the conventional cut-off score of 6 sugges-
tive of depression), and APOE ε4 genotype (yes/no) were
added as covariates (Model 2). Because a significant amount
of residual variance remained after adding the covariates,
Model 3, which included the groups (CO, SCD-C, SCD1C)
as predictor variables, was generated. To reduce the
complexity of this final model, only variables indicative of
a significant trend in Model 2 (P , .1) remained in Model
3 [34]. To derive a plot of the three group trajectories, a
multigroup analysis with stratification by group was
conducted.
The CO group was compared with the SCD1C and SCD-
C groups using group contrasts adjusted for significant
covariates. Three latent factors—intercept (baseline perfor-
mance), linear slope (change rate), and quadratic slope
(quadratic change rate)—were investigated and tested for
significance.
In the second set of analyses, only CO subjects (no SCD
at baseline) were included. In those, who reported SCD at
some point during follow-up, the initial report of SCD-C
or SCD1Cwas defined as incident SCD. Subjects were clas-
sified as incident SCD-C if they did report SCD-C, but did
not report SCD1C at any follow-up. They were categorized
as SCD1C if they additionally showed a concern regarding
memory at any follow-up. Thus, a subject reporting no SCD
at baseline, SCD-C at follow-up 1, and SCD1C at follow-up
2 was classified as incident SCD1C, with an onset of SCD at
follow-up 1. We modeled the trajectories of each cognitive
domain before and after incident SCD. We compare stable
CO subjects (who never reported SCD) to subjects with inci-
dent SCD-C or SCD1C. The time point of incident SCD at
follow-up was recoded as zero to estimate cognitive trajec-
tories. In this analysis, the time point zero is incident SCD.
The previous time point was recoded as 21, 22, 23, etc.,
whereas the time points after the incident SCD were recoded
as11,12,13, etc. Each time point represents an interval of
18 months (Fig. 2).
By overlaying the trajectories at time point 0, we obtained
group trajectories with up to five time points before and after
incident SCD. The stable CO group trajectories during
follow-up were randomly assigned to the starting time points
by computing a uniformly distributed random integer in the
range between one and five, similar to the proportional dis-
tribution of incident SCD. Sample sizes at the extremes were
not sufficient for statistical modeling (n , 20). Thus, the
analysis was restricted to three time points before and four
time points after incident SCD. The preprocessed data
were fitted with piecewise linear growth models [35].
Mean change over time from time point 23 to incident
SCD was represented as the linear slope before SCD. Inci-
dent SCD to time point 14 was represented as theslope after SCD. The time point zero (incident SCD) was
the common intercept of the two slopes. The stable CO
group was compared with the incident SCD1C and
incident SCD-C groups using group contrasts adjusted for
covariates.
To control for false positive results we considered only re-
sults with P , .01 to be significant.2.6. Predicting incident dementia hazard
In addition to the cognitive trajectories, Cox proportional
hazards regression analysis was performed with SPSS 21
(IBM) to model the risk of incident Alzheimer’ dementia
and of all dementia types as a function of group membership
and of the covariates age, gender, education, depression, and
APOE ε4 genotype.3. Results
The three groups differed significantly in terms of gender
and education, but not in age, APOE ε4 genotype, and
MMSE (Table 1). Follow-up rates did not differ between
groups (c2 (8) 5 7.814; P 5 .452 n.s.).
In both sets of analyses, the final models of the cognitive
trajectories had a good fit throughout (RMSEA , 0.04,
CFI . 0.97) and outperformed the unconditional (Model
1) and covariate (Model 2) models. Further details on model
fit can be provided by the corresponding author on request.3.1. Baseline cognitive performance
All groups differed significantly from each other in de-
layed recall performance with the CO group performing
the best, followed by the SCD-C and SCD1C groups (see
Fig. 1 and Table 2). In addition, the adjusted group contrasts
between CO and SCD1C, and SCD-C and SCD1C, were
significant for immediate recall and for the word fluency
task. There were no significant differences in working mem-
ory and global cognition between groups.3.2. Cognitive decline trajectories
Fig. 1 displays the estimated means of cognitive trajec-
tories (see Supplementary Material for observed means)
for the three groups.
In delayed recall, the adjusted group contrasts of the
linear slope revealed significant differences in decline over
time between CO and SCD1C, at a trend level between
CO and SCD-C, and between SCD-C and SCD1C (see
Table 2 and Fig. 1B).
The adjusted group contrasts for immediate recall also
showed significant differences between the CO and SCD-
C, CO and SCD1C groups, and SCD-C and SCD1C
groups. In global cognition, there were significant differ-
ences between CO and SCD-C groups, CO and SCD1C
groups, and SCD-C and SCD1C groups. There were no
Fig. 1. Trajectories of estimated means for controls (CO), SCD without concerns (SCD-C) and SCD with concerns (SCD1C) controlling for age, gender, ed-
ucation apolipoprotein ε4 -genotype and depression at baseline.
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word fluency and working memory.
Models with reduced follow-up time revealed that the
rates of decline in all domains were not significantly
different before follow-up 4 (respectively, 6 years). Thus,
SCD-associated cognitive decline became apparent only 6
years after baseline.
There was no group difference in the quadratic slope in
any of the cognitive domains.3.3. Covariate effects
Covariate effects for the first set of analyses are presented
in the Supplementary Material.3.4. Cognitive performance and incident SCD
Of the 993 individuals free of SCD at baseline, 361 sub-
jects reported SCD without concerns and 146 reported SCD
Fig. 2. Trajectories of estimated means for stable controls (CO), converters into SCD without concerns (SCD-C) and converters into SCD with concerns
(SCD1C), controlling for age, gender, education apolipoprotein ε4-genotype and depression (at baseline).
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median distance of first SCD report from baseline was four
assessments (6 years). Fig. 2 shows the cognitive trajectories
(estimated means, see Supplementary Material for observed
means) before and after incident SCD. Table 3 lists the sta-
tistical comparisons.
At the time point of incident SCD, those with incident
SCD1C had poorer delayed recall than stable CO. A
similar trend was observed for incident SCD-C. There
was a significant difference in the slope of delayed recallperformance between groups. Although the stable CO
increased their performance (possibly due to test repetition
effects), the other groups showed a decline in delayed recall
preceding their incident SCD (CO vs. SCD-C, CO vs.
SCD1C).
A similar pattern was observed for immediate recall:
At incident SCD, those with incident SCD1C had poorer
immediate recall performance than those with stable CO.
The same was observed for incident SCD-C. The immedi-
ate recall slopes before incident SCD differed
Table 1
Sample description for groups with and without subjective cognitive decline at baseline
Groups
Total sample
Group differences
between
the three groups
Significant post-hoc
testsCO SCD-C SCD1C
n 993 965 372 2330
Rate of follow-up in % at
follow-up1
85.7 88.8 83.5 c2 (8, N5 2330)5 7.814,
P 5 .452, n.s.
Rate of follow-up in % at
follow-up2
73.1 76.6 72.9
Rate of follow-up in % at
follow-up3
58.4 62.7 58.0
Rate of follow-up in % at
follow-up4
47.6 51.3 48.5
Rate of follow-up in % at
follow-up5
36.6 40.6 35.8
MMSE: mean (SD) 27.97 (1.49) 27.95 (1.51) 27.88 (1.55) 27.95 (1.51) P 5 .672
Age in years: mean (SD) 79.39 (3.40) 79.73 (3.56) 79.72 (3.60) 79.58 (3.50) P 5 .065
Female, n (%) 661 (66.6) 566 (58.7) 263 (70.7) 1490 (63.9) c2 (2, N5 2330)5 22.04,
P , .0001
*,z
Level of education c2 (4, N5 2330)5 16.26,
P , .003
*,y,z
Low, n (%) 675 (68.0) 618 (64.0) 262 (70.4) 1555 (66.7)
Middle, n (%) 241 (24.3) 233 (24.1) 67 (18.0) 541 (23.2)
High, n (%) 77 (7.8) 114 (11.8) 43 (11.6) 234 (10.0)
APOE ε41, n (%) 195 (19.6) 201 (20.8) 78 (21.0) 0.20 (20.3) c2 (2, N 5 2330) 5 0.54,
P 5 .765
Incident Alzheimer’s
dementia within five
follow-ups: n
51 88 53 192
Risk, incident
Alzheimer’s dementiax
hazard ratio, P-value
(CI)
1.0 1.64
P 5 .005 (1.16–2.32)
2.89
P 5 .000 (1.96–4.26)
-
Incident dementia within
five follow-ups: n
88 129 87 304
Risk, incident dementiax
hazard ratio, P-value
(CI)
1.0 1.41
P 5 .014 (1.07–1.85)
2.63
P , .001 (1.95–3.55)
-
Abbreviations: CO, controls (without subjective cognitive decline); SCD-C, SCD (subjective cognitive decline) without concerns; SCD1C, SCD with con-
cerns; SD, standard deviation; APOE ε4, apolipoprotein ε4; FU, follow-up interval was 18 months; MMSE, Mini-Mental State Examination; CI, confidence
interval; n.s., non-significant.
NOTE. Covariates: age, sex, education (low, medium, high), depressive symptoms (Geriatric Depression Scale scores ,6 points or 6).
Bolded text indicates significant hazard ratio. Italicized text indicates significant P-values.
*CO vs. SCD-C.
yCO vs. SCD1C.
zSCD-C vs. SCD1C.
xCO group 5 reference group.
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CO and SCD1C.
For word fluency, therewere no significant intercept differ-
ences at incident SCD, but before incident SCD there were
significant differences in the slopes between the stable CO
group and the incident SCD-C and incident SCD1C groups.
There was no significant difference in decline between
the groups in working memory either in the intercept at inci-
dent SCD or in the slope before incident SCD.
In global cognition, there was a significant difference in
performance at incident SCD between SCD-C and SCD1C.
Incident SCD1C was preceded by a significant decline in
global cognition before incident SCD compared with CO,
and also compared with SCD-C.In none of the studied cognitive domains, there was a
group difference in slope after incident SCD.3.5. Cox regression of SCD as a predictor of incident
dementia
In addition to the GCM analyses, we performed a Cox
regression analysis to assess the risk of baseline SCD on
future dementia of AD-type and of all cause dementia. For
AD-type dementia, SCD1C showed a 2.89 times increased
risk (P , .001) and SCD-C showed a 1.64 times increased
risk (P 5 .005) for over five follow-ups in comparison
with CO. For dementia of all cause, SCD1C showed a
Table 2
Results of the growth factor estimates with regard to baseline groups
Immediate recall Delayed recall Word fluency Working memory MMSE
Estimate P-value Estimate P-value Estimate P-value Estimate P-value Estimate P-value
Intercept
CO vs. SCD-C 20.352 .080 20.073 .004 0.015 .947 0.040 .315 20.010 .869
CO vs. SCD1C 20.389 .000 20.252 .000 20.313 .034 0.026 .376 0.064 .125
SCD- vs SCD1C 20.504 .020 20.271 .029 20.713 .020 0.019 .732 0.132 .118
Slope
CO vs. SCD-C 20.352 .008 20.093 .060 0.018 .915 20.017 .218 20.110 .005
CO vs. SCD1C 20.410 .000 20.157 .000 20.130 .238 20.008 .359 20.180 .000
SCD- vs. SCD1C 0.412 .024 20.182 .044 20.267 .233 20.007 .742 20.246 .000
Quadratic slope
CO vs. SCD-C 0.027 .354 0.051 .358 20.029 .404 * *
CO vs. SCD1C 0.035 .079 0.014 .142 20.027 .246
SCD- vs SCD1C 0.033 .393 0.014 .451 20.024 .606
Abbreviations: CO, controls (without subjective cognitive decline); SCD-C, SCD (subjective cognitive decline) without concerns; SCD1C, SCD with con-
cerns; MMSE, Mini-Mental State Examination.
NOTE. In all cognitive domains, P-values are corrected for age, gender, education, depression, and apolipoprotein ε4 genotype.
Bold text indicates significant group contrasts.
*Only linear slope was fitted to the data.
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showed a 1.4 times increased risk (P 5 .014).4. Discussion
Overall, our results show that a report of subjective mem-
ory decline, a specific form of SCD, in cognitively normal
elderly may predict future objective memory decline and
incident dementia. Furthermore, incident subjective mem-
ory decline may also reflect past cognitive decline.
As expected, SCD at baseline predicted accelerated
decline in episodic memory over 8 years, and the decline
was more pronounced in SCD1C. This confirms prior re-Table 3
Results of the growth factor estimates with regard to incident SCD
Immediate recall Delayed rec
Estimate P-value Estimate
Intercept—incident SCD
Stable CO vs. converters into SCD-C 20.724 .034 20.338
Stable CO vs. converters into SCD1C 20.615 .005 20.332
Converters into SCD-C vs. converters into
SCD1C
20.490 .242 20.329
Slope before SCD
Stable CO vs. converters into SCD-C 20.370 .005 20.234
Stable CO vs. converters into SCD1C 20.161 .105 20.174
Converters into SCD-C vs. converters into
SCD1C
0.038 .850 20.108
Slope after SCD
Stable CO vs. converters into SCD-C 0.149 .449 20.004
Stable CO vs. converters into SCD1C 20.025 .827 20.095
Converters into SCD-C vs. converters into
SCD1C
20.189 .342 20.184
Abbreviations: CO, controls (without subjective cognitive decline); SCD-C, SC
cerns; MMSE, Mini-Mental State Examination.
NOTE. In all cognitive domains, P-Values are corrected for age, gender, educa
Bold text indicates significant group contrasts.ports [15–17]. The other cognitive decline measures were
largely unrelated to the subjective report on memory,
suggesting some degree of specificity regarding the
association of subjective and objective decline.
Apart from different cognitive trajectories, we also found
baseline differences in episodic memory between groups,
particularly in the SCD1C group. As expected, greater
age, male gender, lower education, depressive symptoms,
and having the APOE ε4 genotype were associated with
poorer baseline cognition, but the effects of SCD were inde-
pendent from these covariates. Known effects on cognitive
decline were replicated in our study. In line with Caselli
et al. [36], APOE ε4 had an effect on delayed recall, butall Word fluency Working memory MMSE
P-value Estimate P-value Estimate P-value Estimate P-value
.060 20.321 .440 20.005 .949 0.111 .413
.003 20.287 .308 0.027 .633 20.148 .106
.139 20.268 .589 0.082 .451 20.389 .009
.001 20.399 .012 20.035 .378 0.006 .922
.001 20.265 .020 0.018 .587 20.137 .006
.279 20.120 .612 0.070 .300 20.267 .003
.970 20.137 .518 0.013 .803 20.027 .796
.101 20.252 .055 20.045 .237 20.063 .384
.065 20.301 .138 20.096 .115 20.118 .273
D (subjective cognitive decline) without concerns; SCD1C, SCD with con-
tion, and apolipoprotein ε4 genotype.
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shape of the trajectories, in line with Gomeni et al. [37],
depression had an effect on baseline, but no effect on verbal
memory decline, in line with Royall et al. [38]. Education
was associated with better baseline performance in all mea-
sures.
A novel finding of this study is that, in subjects free of
SCD at baseline, incident SCD was preceded by objective
memory decline. For delayed recall and also for verbal
fluency, the slope of decline in the 4.5 years before incident
SCD was stronger in the SCD-C and SCD1C group. Subtle
objective decline therefore precedes, and possibly also gives
rise to, the report of SCD, supporting the concept that SCD
may indicate a subtle decline in cognitive function [1]. This
temporal sequence was evident in group analyses but would
probably not be detectable on an individual basis.
It is not possible with the present data to exactly deter-
mine the time lag between objective and subjective decline.
The answer to this question will, however, also depend on
the relative sensitivity of the objective and subjective decline
assessments used.
Amieva et al. [39] showed that cognitive complaints, as-
sessed with a questionnaire, increased on an average 7 to
8 years before the diagnosis of Alzheimer’s dementia,
whereas verbal fluency started to drop 12 years before diag-
nosis. Amieva et al. did not focus on the SCD individuals
themselves but their findings are in line with the sequence
proposed by this paper. Stewart et al. [40] found that hippo-
campal atrophy over 4 years preceded incident SCD and this
could also be a cause of the memory decline preceding SCD
in the current sample.
We here focused on prevalent SCD and incident SCD.
However, like other phenotypical classifications (e.g.
MCI), SCD is unlikely to be absolutely stable over time.
It will be an interesting issue for further research to study
the determinants and consequences of SCD stability over
time.
In subjects without SCD at baseline or during follow-up,
there is a slight increase in memory test scores over the
years, probably due to test repetition effects [41]. However,
these test repetition effects appear to be outpaced by mem-
ory decline in the SCD groups. Reduced test repetition ef-
fects in the CERAD word list learning task have also been
described before in patients with mild AD [42].
The strengths of our study include the large sample size,
themulticentre design, and long follow-up time, the availabil-
ity ofAPOE ε4 genotyping and application of GCM. The lim-
itations of our study include the lack of brain imaging. Our
data do not allow us to elucidate the brain changes that under-
lie incident SCD. However, elderly help-seeking subjects
with SCD (but without mild cognitive impairment) show
signs of brain atrophy in the entorhinal cortex [43] and hippo-
campus [44], glucose metabolism changes [45], and
increased PittsburghCompound B Positron Emission Tomog-
raphy beta-amyloid load [46]. Many of these characteristics
are indicative of and consistent with the preclinical stagesof AD. In addition, SCD has been associated with AD-like
pathology in autopsy studies [47,48].
In sum, this study shows that a report of memory decline
in old age is partly related to ongoing (past and future) mem-
ory decline, and is not merely a depressive interpretation of
normal age-related cognitive loss. Furthermore, our data
suggest that at the group level, subjects begin to report inci-
dent SCD after their memory starts to deviate from
normal. This would be consistent with the “self-experience
of decline” hypothesis of SCD in the context of
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1. Systematic review: Subjective cognitive decline
(SCD) in memory appears to be a risk factor for
future cognitive decline and dementia. The associa-
tion with trajectories of decline in individual cogni-
tive domains and potentially SCD-preceding
cognitive decline are not well studied. The authors
investigated a large epidemiological cohort from
Germany to address these questions.
2. Interpretation: Subjective decline in memory and
related concerns (SCD1C) are related to subtle
decline in memory performance. They are risk fac-
tors for future decline in memory functions. Before
the onset of SCD, memory decline already occurred.
3. Future directions: The study further supports the
concept of SCD as a risk factor for cognitive decline
and an indicator of very first impairment of cognitive
performance in elderly. These results can aid in
designing future prevention trials.References
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